Table 2.
New scientific tools and techniques applied (+) or not applied (–) in NexGen case study prototypes.
| Scientific tools and techniques | Tier 1 | Tier 2 | Tier 3 | |||
|---|---|---|---|---|---|---|
| Hydrocarbon mixtures and cancer | Oil spill dispersants and endocrine disruption | Chemical exposure and cancer, reproductive, and developmental hazards | Multiple stressors and diabetes | Ozone and lung injury | Benzene and leukemia | |
| Hazard identification and dose–response assessment methods | ||||||
| Quantitative structure–activity models | + | + | + | – | – | – |
| Toxicity pathway analysis | + | + | + | + | + | + |
| High throughput in vitro assays | – | + | + | + | + | + |
| High content “omics” assays | – | – | + | – | + | + |
| Molecular and genetic population-based studies | – | – | – | – | + | + |
| Biomarkers of effect | – | – | – | + | + | + |
| Dosimetry and exposure assessment methods | ||||||
| In vitro to in vivo extrapolation | + | + | + | – | – | – |
| Pharmacokinetic models and dosimetry | – | + | + | – | + | + |
| Biomarkers of exposure | – | – | – | + | + | + |
| Exposomics | – | – | – | – | – | – |
| Cross-cutting assessment methods | ||||||
| Adverse outcome pathways | + | + | + | + | + | + |
| Bioinformatics/computational biology | + | + | + | + | + | + |
| Functional genomics | – | – | + | + | + | + |
| Systems biology | + | – | + | + | + | + |